The vicious cycle of apoptotic beta-cell death in type 1 diabetes (Q36885374)

16 August 2017

1 reference

title

The vicious cycle of apoptotic beta-cell death in type 1 diabetes (English)

1 reference

16 August 2017

0 references

0 references

Ayelet Kaminitz

1

1 reference

16 August 2017

Jerry Stein

series ordinal

2

1 reference

16 August 2017

Isaac Yaniv

series ordinal

3

1 reference

16 August 2017

Nadir Askenasy

series ordinal

4

1 reference

16 August 2017

17 July 2007

1 reference

Immunology & Cell Biology

16 August 2017

1 reference

16 August 2017

85

1 reference

16 August 2017

8

1 reference

16 August 2017

582-589

1 reference

Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?

16 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Role of beta-cells in type 1 diabetes pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Does physiological beta cell turnover initiate autoimmune diabetes in the regional lymph nodes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Role of dendritic cells in the induction and maintenance of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Pancreatic islets under attack: cellular and molecular effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Antigen-specific induction of regulatory T cells for type 1 diabetes therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Immunotherapy for the prevention and treatment of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Back to central tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Immunology: Insulin auto-antigenicity in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Gene- and cell-based therapeutics for type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Diabetogenic T-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

CD4+ and CD8+ T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

The role of CD4 vs. CD8 T cells in IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Myeloid dendritic cells in non-obese diabetic mice have elevated costimulatory and T helper-1-inducing abilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Defect in activation-induced cell death in non-obese diabetic (NOD) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Contribution of Fas to diabetes development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Mechanisms of beta cell death in diabetes: a minor role for CD95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Significant role for Fas in the pathogenesis of autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Induction of tolerance using Fas ligand: a double-edged immunomodulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Mouse islet cell lysis mediated by interleukin-1-induced Fas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

The role of Fas-FasL in CD8+ T-cell-mediated insulin-dependent diabetes mellitus (IDDM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Role of cytokines in the pathogenesis of autoimmune diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Tumor necrosis factor: a master-regulator of leukocyte movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

In vivo control of diabetogenic T-cells by regulatory CD4+CD25+ T-cells expressing Foxp3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Is there a role for nitric oxide in beta-cell dysfunction and damage in IDDM?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Death effectors of beta-cell apoptosis in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

beta-Cell death during progression to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Transmembrane TNF and IFNgamma induce caspase-independent death of primary mouse pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Fas is expressed in murine pancreatic islet cells and an insulinoma cell line but does not mediate their apoptosis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Fas is detectable on beta cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kappaB and C/EBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

A biphasic role of nuclear transcription factor (NF)-kappaB in the islet beta-cell apoptosis induced by interleukin (IL)-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFkappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Beta cell MHC class I is a late requirement for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

T helper cell subsets in insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Following a diabetogenic T cell from genesis through pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Immunotherapy of NOD mice with bone marrow-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Dendritic Cells Transduced to Express Interleukin-4 Prevent Diabetes in Nonobese Diabetic Mice with Advanced Insulitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Fas deficiency prevents type 1 diabetes by inducing hyporesponsiveness in islet beta-cell-reactive T-cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Apoptosis of autoreactive CD8 lymphocytes as a potential mechanism for the abrogation of type 1 diabetes by islet-specific TNF-alpha expression at a time when the autoimmune process is already ongoing.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

The role of Fas ligand in beta cell destruction in autoimmune diabetes of NOD mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Fas and Fas ligand immunoexpression in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

The role of CD8+ cells, cell degeneration, and Fas ligand in insulitis after intraperitoneal transfer of NOD splenocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

The role of Fas ligand in the development of insulitis in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In Vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Distinction between interleukin-1-induced necrosis and apoptosis of islet cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

IL-1 receptor deficiency slows progression to diabetes in the NOD mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Macrophage cytotoxicity towards isolated rat islet cells: neither lysis nor its protection by nicotinamide are Beta-cell specific

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

The role of cytokines as effectors of tissue destruction in autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Cytokines activate the nuclear factor kappa B (NF-kappa B) and induce nitric oxide production in human pancreatic islets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100093

7 January 2021

Identifiers

DOI

10.1038/SJ.ICB.7100093

1 reference

16 August 2017

1 reference